Barclays Reiterates Overweight Rating for Assura (LON:AGR)

Assura (LON:AGRGet Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Barclays in a research report issued on Friday, Marketbeat reports. They currently have a GBX 53 ($0.66) target price on the real estate investment trust’s stock. Barclays‘s price target suggests a potential upside of 24.41% from the stock’s current price.

A number of other research analysts have also recently weighed in on the company. Berenberg Bank lifted their price objective on Assura from GBX 49 ($0.61) to GBX 51 ($0.64) and gave the company a “buy” rating in a research report on Monday, November 20th. Shore Capital initiated coverage on shares of Assura in a research note on Thursday, November 16th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of GBX 56.25 ($0.71).

Check Out Our Latest Research Report on AGR

Assura Trading Down 0.7 %

LON:AGR opened at GBX 42.60 ($0.53) on Friday. The firm has a market capitalization of £1.27 billion, a price-to-earnings ratio of -710.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.30. The company has a debt-to-equity ratio of 82.21, a current ratio of 1.29 and a quick ratio of 2.84. The business has a fifty day moving average price of GBX 45.66 and a 200-day moving average price of GBX 44.69. Assura has a one year low of GBX 38.38 ($0.48) and a one year high of GBX 54.60 ($0.68).

Insider Buying and Selling at Assura

In other news, insider Jayne Cottam acquired 728 shares of Assura stock in a transaction on Tuesday, December 5th. The shares were acquired at an average price of GBX 45 ($0.56) per share, with a total value of £327.60 ($410.68). Insiders purchased 1,397 shares of company stock valued at $62,811 in the last 90 days. Insiders own 0.24% of the company’s stock.

Assura Company Profile

(Get Free Report)

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

Featured Articles

Analyst Recommendations for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.